Key Developments

In March 2021, Smith+Nephew, a medical technology company, unveiled findings from a real-world study conducted in Spain, demonstrating that transitioning to ALLEVYN LIFE Foam Dressings notably decreased dressing change frequency and weekly dressing expenses, alongside enhancing treatment satisfaction for both clinicians and patients in a community environment
In February 2021, Axis Biosolutions, a deep-science medical technology, obtained European CE mark approval for MAxiCel, an advanced wound care product designed for various chronic wounds, such as pressure ulcers
In September 2020, Integra LifeSciences Holdings Corp., a medical technology company, finalized a definitive agreement to divest its Extremity Orthopedics business to Smith+Nephew
In March 2020, Smith+Nephew introduced the PICO 14 Single Use Negative Pressure Wound Therapy System specifically designed for application on high-risk surgical patients
In February 2020, Integra LifeSciences Holding Corporation unveiled the AmnioExcel Plus Placental Allograft Membrane, its newest wound care solution aimed at bolstering soft tissue repair

Pressure Ulcers Treatment Market Report Snapshots